There are situations where chipboard have uplisted because they were above the mark when told they need to supply more data to finalize the uplist. when they actually uplisted they were under 2. If all NASDAQ needed was the audited 10k then basically Cellceutix was approved/pending at the end of June. they were week above the approved 2 at that time. it's just a maybe, but my dines are crossed. well the shorts have to cover of we uplist?